Skip to content
Recall Observatory FDA recall evidence

Drug product

Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx only, Manufactured for: Prasco Laboratories Mason, OH 45040 USA, Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810, NDC 66993-680-30

D-1314-2020

May 26, 2020

Class III

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 85756
Status
Terminated
Classification
Class III
Quantity
13322 bottles
Official record key
drug-enforcement:D-1314-2020

Official wording

Reason: Failed Impurities/ Degradation Specifications

Code information: Lot #: 561180046A1, Exp 8/2020

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Impurities/ Degradation Specifications